SCI Rep: new nanocapsules or promising for the treatment of type 1 and type 2 diabetes

January 15, 2020 / bioun / -- recently, in a research report published in the international journal scientific reports, scientists from the University of Curtin in Australia developed a new nano capsule, which may effectively target the liver and pancreatic gland, thus reducing the inflammatory effect of two types of diabetes Photo source: in the Curtin University article, the researchers used the Biological Nanotechnology to research and developed the micro nano capsule by combining the bile acid based on human body with the lipid-lowering drug probucol In the study of the mouse model for up to six months, the researchers found that the nano capsule can effectively target diabetes The inflammatory effect Researcher Hani al salami, Ph.D., said the nanocapsules can preferentially target specific organs and enhance the transport potential of active agents, thereby reducing their potential damage to other organs of the body With advanced and customized biological nano technology, the nano capsule developed by researchers can protect the active pharmaceutical preparation against the digestion and absorption process of the body, thus promoting the absorption of bile acid and probucol by the liver and pancreas These two organs often appear inflammation in the body of diabetic patients The researchers point out that the nanocapsules containing bile acid and probucol can effectively reduce diabetes The results of this study are of great significance for the later scientists to develop new diabetes, and the later researchers need to further study to determine whether this therapy can also play a role in human body Finally, researcher al salami said, this study reveals the relevance and importance of Using Biological Nanotechnology and tissue-targeted transport technology in diabetic animal models Using these advanced technologies, researchers may be expected to develop new therapies to reduce the progress and severity of diabetes in the future Original source: Armin mooranian et al Bill acid bio nanoencapsulation improved drug targeted delivery and physiological effects via cellular flux: 6-months diabetes preclinical study, scientific reports (2020) Doi: 10.1038/s41598-019-53999-1